Neurotech International Ltd. has released a press release.
Neurotech secures $3.15 million R&D tax incentive loan
Earlier from Neurotech International
- US FDA clears IND for NTI164
- NTI secures Notices of Allowance for US patent applications
- NTI initiates First Clinical Site for Phase 3 ASD Trial
- Appendix 4D & Half Year Report